The Nifty Pharma index was trading 2.15 per cent down at 8,222 around 02:50 pm.
May 9 (Reuters) - Below are the ratings awarded by India Ratings and Research Private Ltd (India Ratings), formerly known as Fitch Ratings India for local debt instruments as of...
Aurobindo Pharma (NS:ARBN) Ltd opened gap up at 594 and rose up sharply to make a high of 610 and closed at 607. The stock has recently seen a fall from the levels of 750 and kept...
Last Trading Session: Indian Stock Market opened flat as predicted by EquityPandit. EquityPandit predicted that market has entered into negative zone and traders should go short at...
|Type||5 mins||15 mins||Hourly||Daily||Monthly|
|Moving Averages||Buy||Strong Buy||Buy||Sell||Sell|
|Technical Indicators||Strong Buy||Strong Buy||Strong Buy||Sell||Strong Sell|
|Summary||Strong Buy||Strong Buy||Strong Buy||Sell||Strong Sell|
Filter Table By:
|Pattern||Timeframe||Reliability||Candles Ago||Candle Time|
|Engulfing Bearish||5H||1||May 25, 2018 06:30|
|Deliberation Bearish||5H||2||May 24, 2018 15:30|
|Bullish Engulfing||1D||3||May 22, 2018|
|Bullish Engulfing||1H||4||May 25, 2018 11:30|
|Three Outside Down||1M||5||Dec 17|
|Tata Steel Ltd||568.25||570.80||552.00||+20.05||+3.66%||8.90M||25/05|
Aurobindo Pharma Limited is a pharmaceutical company. The Company is engaged in producing oral and injectable generic formulations and active pharmaceutical ingredients (APIs). Its product portfolio is spread over seven therapeutic/product areas, including antibiotics, anti-retrovirals, cardiovascular, central nervous system, gastroenterologicals, anti-allergies and anti-diabetics. It is engaged in developing a range of oncology and hormonal products. It is also developing inhalation and dermatology products, such as pressurized metered-dose inhaler (pMDI). It markets its products through chain stores in the United States. It has developed over three injectable penem products. The Company, through its subsidiary, manufactures and sells nutritional supplements. It has over 10 manufacturing units and approximately two research and development centers. The Company, in addition to marketing its products domestically, also markets its products globally in over 150 countries.Read More
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.